Digital Sphygmomanometer Market Research, 2031
The global digital sphygmomanometer market size was valued at $942.6 million in 2021, and is projected to reach $1,560.50 million by 2031, growing at a CAGR of 5.2% from 2022 to 2031. A digital sphygmomanometer is a fully or semi-automated, simple, lightweight machine used for monitoring blood pressure. It measures blood pressure and pulse simply quickly, easy to use, reliable and portable. Digital blood pressure monitors are battery operated and consist of a case with on/off switch, start button, and in some machines a pre-set switch and memory button. Digital sphygmomanometer works on oscillometric method, which depends on the transmission of intra-arterial pulsations through the occluded arm. Digital sphygmomanometers provide BP measurements on demand by the clinician or after pre-set intervals without a clinician present.
Historical Overview
The digital sphygmomanometer market was analyzed qualitatively and quantitatively from 2021-2031. The digital sphygmomanometer market grew at a CAGR of around xx % during 2021-2031. Most of the growth during this period was derived from the Asia-Pacific owing to the increase in demand by consumers, rise in investments for development of digital sphygmomanometer and increase in number of key players manufacturing digital sphygmomanometers.
Market Dynamics
Growth & innovations in the pharmaceutical industry for the launching of digital sphygmomanometers owing to massive pool of health-conscious consumers, creates an opportunity for the digital sphygmomanometer market. Rise in launch of various digital sphygmomanometer, rise in investments for manufacturing of advanced digital sphygmomanometer by various key players across the globe is set to affect the market growth positively. In addition, rise in adoption of digital sphygmomanometer by hospitals and clinics is observed, owing to higher accurate results obtained which is expected to propelled the growth of digital sphygmomanometer market.
Hypertension is a global public health burden and a major cause of morbidity and mortality worldwide, with rise in number of geriatric populations suffering from high blood pressure is observed, which results in demand of accurate and ambulatory blood pressure monitoring. In addition, patients with long term blood pressure disorder, are advised to continuously monitor blood pressure, thus adopt digital sphygmomanometer at home care setting, thus driving the digital sphygmomanometer market opportunity.
Along with the factors mentioned above, technological advancements in the field of digital sphygmomanometer such as the development of new techniques to enhance the yield and diagnostic accuracy are also expected to aid in the growth of market. Furthermore, various key players are adopting key strategies such as alliance and collaboration for advancements in digital sphygmomanometers and offer accurate monitoring devices. For instance, in April 2020, AliveCor and OMRON Announce Global Strategic Alliance for Comprehensive Remote Cardiovascular Monitoring. The rise in the incidence of cardiovascular diseases has resulted rise in demand of advanced digital sphygmomanometers with physiological parameters in quick time thereby, significantly influencing the demand for the market. Various organizations along with government are counselling physicians and patients regarding digital sphygmomanometers and applications of it. In addition, rise in investments by various governments in digital technology for healthcare sector is expected to propel the growth of market. For instance, according to report of Ministry of Health and Family Welfare, Government of India, stated that, 80 percent rise in investments for digital technology for healthcare is observed which drives the growth of market.
The demand for digital sphygmomanometer is not only limited to developed countries but is also being witnessed in the developing countries, such as China, Brazil, and India, which fuels the growth of the market. Factors such as rise in adoption of digital sphygmomanometers, and increase in awareness toward use of wrist type digital sphygmomanometers, furthers drives the growth of the market. Moreover, increase in promotional activities by manufacturers and growth in awareness about digital sphygmomanometer and rise in demand of digital sphygmomanometer for at home monitoring is expected to fuel their adoption in the near future.
However, inaccurate results obtained by digital sphygmomanometers restrains the growth of the digital sphygmomanometer market. In addition, high cost of digital sphygmomanometers is expected to restrain the growth of the market. In contrast, this provides opportunity of R&D activities for better advancements in these products delivery and more accurate results to the market players of digital sphygmomanometer market.
The outbreak of COVID-19 has disrupted workflows in the health care sector around the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. The COVID-19 pandemic positively impacted to the growth of digital sphygmomanometer market, owing rise in adoption of digital sphygmomanometers especially in home care setting. Many patients suffering from long term hypertension were advised to monitor blood pressure at home using digital sphygmomanometers to prevent the spread of infection and potentially reduce cross-infections by reducing staff-to-patient contact. Further, rise in use of disposable cuffs for arm type digital sphygmomanometers were preferred for critically ill patients to prevent the cross infection. In addition, advanced digital sphygmomanometers offered wireless transfer of patient information to physicians, along with irregular heartbeat symbol, thereby useful for geriatric and critically ill patients. Further, rise in number of hospitals and clinic centers during pandemic led to adoption of digital sphygmomanometers. Thus, pandemic positively impacted the growth of digital sphygmomanometer market.
Segmental Overview
The digital sphygmomanometer market is segmented into type, end user and region. By type, the market is categorized into arm devices and wrist devices. On the basis of end user, the market is segregated into hospitals and clinics, ambulatory surgical centers and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
By Type:
The market is bifurcated into arm devices and wrist devices. The arm devices segment accounted for the largest digital sphygmomanometer market share in 2021, and is also expected to remain dominant during the forecast period, owing to rise in adoption of this devices owing to higher accuracy and recommended by national health authorities of many countries. The wrist devices segment is projected to register highest CAGR during forecast period owing increasing popularity of these devices as these devices offer comfortability and less pain during monitoring of blood pressure.
By End User:
The market is categorized into hospitals and clinics, home care settings & others. The hospitals and clinics segment occupied the largest digital sphygmomanometer market share in 2021 owing to preference of large number of patients and owing cost effectiveness The home care settingssegment is projected to register highest CAGR during forecast period owing torise in adoption of homecare digital sphygmomanometers with advanced technology which can transfer wireless transfer of patient's information to physicians.
By End User
Hospitals and clinics segment dominated the market in 2021, and home care settings segment is expected to be lucrative during the forecast period.
By Region:
Region wise, North America is occupied the largest digital sphygmomanometer market size, in terms of revenue, owing to increase in adoption of digital sphygmomanometers by physicians & patients, rise in number of hypertension cases and rise in healthcare infrastructure drive the growth of digital sphygmomanometer market. Upsurge in healthcare expenditure in the emerging economies is anticipated to offer lucrative opportunities for the market expansion. However, Asia-Pacific is anticipated to witness notable growth, owing to increase in investments for development of digital sphygmomanometer and increase in number of key players manufacturing digital sphygmomanometers, drives the growth during the digital sphygmomanometer market forecast period.
Presence of several major players, such as OMRON Corporation, Panasonic Holdings Corporation, A & D HOLON Holdings Company Limited, and advancement in digital sphygmomanometers for development of effective devices offering accurate blood pressure measurements in the region is expected to drive the digital sphygmomanometer market size. Furthermore, presence of well-established healthcare infrastructure, and rise in adoption of at home digital sphygmomanometers are expected to drive the market growth. Furthermore, various product launches and rise in investments in digital sphygmomanometer as key strategy adopted by the key players in this region further boost the growth of the market. For instance, in June 2020, Omron healthcare (subsidiary of Omron Corporation) and Mount Sinai Health System have collaborated to help high-risk patients monitor their blood pressure from home with VitalSight, thus such collaboration is expected to drive the digital sphygmomanometer market growth.
Asia-Pacific expected to grow at the highest rate during the forecast period. The market growth in this region is attributable to presence of key players in the region. Moreover, rise in adoption of digital sphygmomanometers for biopharmaceutical manufacturing is anticipated to contribute to the growth of the market. Further, with rapid development of digital technology in health and vast market demand for advanced digital sphygmomanometers in India & China, wireless and advanced digital sphygmomanometers is on rise, which is anticipated to contribute to growth of market. Asia-Pacific offers profitable opportunities for key players operating in the digital sphygmomanometer market, thereby registering the fastest growth rate during the forecast period, owing to the growing infrastructure of industries, as well as well-established presence of domestic companies in the region. In addition, rise in contract manufacturing organizations within the region provides great opportunity for new entrants in this region.
Competition Analysis
Competitive analysis and profiles of the major players in the digital sphygmomanometer market, such A&D HOLON Holdings Company Limited, American Diagnostic Corporation, Baxter International Inc., Contec Medical Systems Co. Ltd, Halma plc, Microlife Corporation, OMRON Corporation, Panasonic Holdings Corporation, Rossmax International Ltd and Yu Yue Medical are provided in this report. Major players have adopted product launch, acquisition, collaboration and alliance agreement, as key developmental strategies to improve the products of the digital sphygmomanometer industry.
Some Examples Of Acquisition In The Market
In December 2021, Baxter International Inc. a global medtech leader, announced today it has completed its acquisition of Hillrom which accelerates product portfolio of Baxter, as Hillrom offers digital sphygmomanometer.
Product Launch In The Market
In January 2019, OMRON Healthcare (subsidiary of OMRON Corporation) officially launches HeartGuide, the first wearable blood pressure monitor, with new digital health service, HeartAdvisor - a digital health service from OMRON with insights and coaching to help users take action on their numbers for their heart health.
Alliance In The Market
In April 2020, AliveCor, a leader in personal ECG products, and OMRON Healthcare, Co., Ltd., a global leader in personal heart health and wellness technology, today announced a global, strategic alliance that combines AliveCor’s ECG technology with industry-leading blood pressure devices from OMRON to better serve customers and expand access to remote patient care.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the digital sphygmomanometer market analysis from 2021 to 2031 to identify the prevailing digital sphygmomanometer industry opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the digital sphygmomanometer market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global digital sphygmomanometer market trends, key players, market segments, application areas, and market growth strategies.
Digital Sphygmomanometer Market Report Highlights
| Aspects | Details |
 Market Size By 2031 | USD 1.6 billion |
 Growth Rate | CAGR of 5.2% |
 Forecast period | 2021 - 2031 |
 Report Pages | 207 |
 By Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Halma plc, Baxter International Inc., Contec Medical Systems Co.,Ltd, OMRON Corporation, Microlife Corporation, A&D HOLON Holdings Company, Limited, Rossmax International Ltd, American Diagnostic Corporation, Yu Yue Medical, Panasonic Holdings Corporation |
Analyst Review
This section provides various opinions of top-level CXOs in the global digital sphygmomanometer market. According to the insights of CXOs, increase in demand for advanced digital sphygmomanometers and rise in investments for digital sphygmomanometer globally is expected to offer profitable opportunities for the expansion of the market. In addition, favorable government initiatives and higher spending for digital sphygmomanometer, has piqued the interest of several companies to develop digital sphygmomanometers.??
CXOs further added that increase in adoption of digital sphygmomanometer for home care setting and private clinics is expected to boost the growth of market. In addition, increasing burden of cardiovascular diseases across the globe has resulted rise in demand for portable and accurate digital sphygmomanometer, thus driving the growth of market. Further, geriatric people are prone to various cardiovascular disorders, thus rise in number of geriatric population results in rise in demand of accurate diagnosis devices with advanced features for monitoring blood pressure, thereby driving the growth of market.?
Furthermore, North America is expected to witness highest growth, in terms of revenue, owing to increase in investments for development of accurate digital sphygmomanometers, increase practice of blood pressure monitoring at home care settings,?and rise in healthcare infrastructure drive the growth of digital sphygmomanometer market. However, Asia-Pacific is anticipated to witness notable growth, owing to increase in investments for development of digital sphygmomanometer and increase in number of key players manufacturing digital sphygmomanometers, drives the growth of market during the forecast period.
Rise in prevalence of blood – related disorders such as hypertension, increase in innovations in digital sphygmomanometer devices are the upcoming trends of digital sphygmomanometer Market
Arm type is the leading type of digital sphygmomanometer.
North America is the largest regional market for digital sphygmomanometer.
Major Key players that operate in the global digital sphygmomanometer market are A&D HOLON Holdings Company Limited (A&D Company, Limited), American Diagnostic Corporation, Baxter International Inc. (Hill-Rom Holdings, Inc), Contec Medical Systems Co.,Ltd, Halma plc (Rudolf Riester gmbh), Microlife Corporation, OMRON Corporation (Omron Healthcare, Inc), Panasonic Holdings Corporation, Rossmax International Ltd and Yu Yue Medical.?
The digital sphygmomanometer market valued for $942.55 million in 2021 and is estimated to reach $1,560.50 million by 2031, exhibiting a CAGR of 5.2% from 2022 to 2031.
2021 is the base year of digital sphygmomanometer market.
2022 to 2031 is the forecast year of the digital sphygmomanometer market.
Loading Table Of Content...
